Business

AdvanSix announces third quarter 2020 financial results

Strong volume growth, cash flow generation, cost management and capital discipline Sales of $282 million, down (9%) versus prior year – Volume up 5%, Pass-through pricing (13%) EPS Loss of ($0.02) – includes $20 million pre-tax income impact of planned plant turnaround

Business, Health Care

LianBio announces $310 million crossover financing

Supported by a strong U.S. and Chinese investor syndicate including Perceptive Advisors, RA Capital, Venrock Healthcare Capital Partners and CMG-SDIC Capital Proceeds will fund advancement of the Company’s global innovation mining platform and diversified portfolio of product candidates SHANGHAI & PRINCETON, N.J.–(BUSINESS